Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stefania Morganti, M.D.

Concepts (98)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms172024207501.060 Why?
High-Throughput Nucleotide Sequencing2201936090.540 Why?
Pharmacogenetics120196610.480 Why?
Receptor, erbB-29202424660.430 Why?
Drug Resistance, Neoplasm3202451590.360 Why?
Neoplasms82024216880.330 Why?
BRCA2 Protein220247890.320 Why?
Data Interpretation, Statistical1201826850.320 Why?
BRCA1 Protein2202411270.290 Why?
Immunoconjugates220238570.240 Why?
Immunotherapy6202445940.240 Why?
Receptors, Estrogen2202321680.240 Why?
Epirubicin12022810.220 Why?
Genomics1201856940.210 Why?
Antineoplastic Agents62024135380.210 Why?
Clinical Trials, Phase III as Topic320208480.200 Why?
Receptors, Fibroblast Growth Factor120211790.190 Why?
Phthalazines120233700.180 Why?
Receptors, Progesterone1202311090.160 Why?
Fluorouracil1202215980.150 Why?
Female2120243821090.140 Why?
Bone Resorption120217170.140 Why?
Cyclophosphamide1202221980.140 Why?
Ketones120171810.130 Why?
Furans120171920.130 Why?
Fibroblast Growth Factors120218590.130 Why?
Antineoplastic Combined Chemotherapy Protocols52024115390.130 Why?
Humans2920247460440.130 Why?
Germ-Line Mutation1202318140.120 Why?
Lymphocytes, Tumor-Infiltrating1202110610.120 Why?
Disease-Free Survival2202267810.120 Why?
Clinical Trials, Phase II as Topic320246260.120 Why?
Neoplasms, Second Primary1202210530.120 Why?
Neoplasm Recurrence, Local2202391700.120 Why?
Carcinoma, Intraductal, Noninfiltrating120219300.120 Why?
Carcinoma, Ductal, Breast1202110830.120 Why?
Chemotherapy, Adjuvant1202234760.120 Why?
Immunologic Factors1202315670.110 Why?
Diagnostic Tests, Routine120187790.110 Why?
Neoplasm Metastasis5202148160.100 Why?
History, 21st Century1201815380.100 Why?
Tumor Microenvironment2202136940.100 Why?
Carcinoma, Non-Small-Cell Lung2202052820.100 Why?
Recurrence1202383730.100 Why?
Clinical Trials, Phase I as Topic220243240.090 Why?
Adiposity1202118220.090 Why?
Prognosis42024290680.090 Why?
History, 20th Century1201827390.090 Why?
Bone Neoplasms1202124950.080 Why?
Randomized Controlled Trials as Topic32020100940.080 Why?
Medical Oncology1202022690.080 Why?
Neoplasm Staging22020110640.080 Why?
Immunohistochemistry12021110360.080 Why?
Protein Kinase Inhibitors2202056070.070 Why?
Lung Neoplasms22020131960.070 Why?
Case-Control Studies12023216730.070 Why?
Treatment Outcome42024636610.060 Why?
Risk Assessment22022234530.060 Why?
Body Mass Index12021126330.050 Why?
Research Design1201860560.050 Why?
Neoadjuvant Therapy2202427870.050 Why?
Disease Progression12018133030.050 Why?
Young Adult22024571060.040 Why?
Immunotoxins120201780.040 Why?
Molecular Targeted Therapy2202127790.040 Why?
Oxazoles120201970.040 Why?
Antibodies, Monoclonal3202091050.040 Why?
Obesity12021126700.040 Why?
Lymphocyte Count120207750.040 Why?
Mutation22021296140.040 Why?
Adult520242149580.040 Why?
Survival Rate22021126320.030 Why?
Retrospective Studies52024782970.030 Why?
Retreatment120176000.030 Why?
Histone Deacetylase Inhibitors120207740.030 Why?
Quinazolines1202013500.030 Why?
Drug Discovery1202110550.030 Why?
Middle Aged620242144120.030 Why?
Breast1202119680.030 Why?
Lymphocytes1202025890.030 Why?
Cancer Vaccines1202010440.030 Why?
Biopsy1202467320.020 Why?
Aged520241642360.020 Why?
Pyridines1202028410.020 Why?
Quality of Life22021129840.020 Why?
Neutrophils1202037060.020 Why?
Aged, 80 and over22024575570.020 Why?
Age Factors12024181460.020 Why?
Kaplan-Meier Estimate1201764530.020 Why?
Cell Proliferation12021103000.020 Why?
Gene Expression Regulation, Neoplastic1202183550.020 Why?
Clinical Trials as Topic1202079350.010 Why?
Male320243510930.010 Why?
Algorithms12020137960.010 Why?
Time Factors12021395870.010 Why?
Signal Transduction12021231120.010 Why?
Animals220211663310.010 Why?
Risk Factors12021724160.010 Why?
Morganti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (98)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.